Kentucky Senator Rand Paul Leads First Congressional Hearing on Gain-of-Function Research
August 5, 2022 | Kentucky
Senator Rand Paul (R-KY) begins the first congressional hearing on gain-of-function research Wednesday, attempting to determine whether the National Institutes of Health (NIH) used taxpayer funds for gain-of-function experiments at the Wuhan Institute of Virology.
“Before we even get to whether the virus came from a lab we have to explore were they doing gain-of-function research?” Paul told Fox News’ Brett Baier Tuesday.
Paul, the ranking member of the Homeland Security & Governmental Affairs Subcommittee on Emerging Threats and Spending Oversight, explained further the importance of the hearings:
Were they taking viruses, mixing them with the unknown viruses and creating more lethal viruses, or viruses that were more infectious or transmissible? I say without question they were doing this. Anthony Fauci says they weren’t.
In May 2021, Paul and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, had a contentious exchange over whether NIH funded gain-of-function experiments at the Wuhan Institute.
“Dr. Fauci dissembled or tried to hide his long time support for ‘gain-of-function’ research which creates super-viruses that jump from animals to humans,” Paul tweeted regarding Fauci’s denial of the creation of the “super-viruses.”… (Excerpt from The Virginia Star)
